BetterLife Pharma Inc

NEW
FRA:NPAU (Canada)  
€ 0.050 -0.00050 (-1%) Mar 28
At Loss
Market Cap:
€ 7.58M ($ 8.25M)
Enterprise V:
€ 10.54M ($ 11.48M)
Volume:
-
Avg Vol (2M):
13.61K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and the European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -36.87
Debt-to-Equity -0.12
Debt-to-EBITDA -0.4
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 39.2
9-Day RSI 38.48
14-Day RSI 39.07
3-1 Month Momentum % -5.47
6-1 Month Momentum % -23.9
12-1 Month Momentum % 9.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.05
Quick Ratio 0.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.1
Shareholder Yield % -13.21

Profitability Rank

Name Current Vs Industry Vs History
ROA % -869.94
ROIC % -1056.99
3-Year ROIIC % -2910.43

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -5.19
EV-to-EBITDA -5.19
EV-to-FCF -7.21
Earnings Yield (Greenblatt) % -19.27
FCF Yield % -19.27

Financials

FRA:NPAU's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

BetterLife Pharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.025
Beta 1.47
3-Year Sharpe Ratio 0.04
3-Year Sortino Ratio 0.07
Volatility % 58.93
14-Day RSI 39.07
14-Day ATR (€) 0.002427
20-Day SMA (€) 0.0531
12-1 Month Momentum % 9.01
52-Week Range (€) 0.0455 - 0.138
Shares Outstanding (Mil) 130.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BetterLife Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

BetterLife Pharma Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

BetterLife Pharma Inc Frequently Asked Questions

What is BetterLife Pharma Inc(FRA:NPAU)'s stock price today?
The current price of FRA:NPAU is €0.05. The 52 week high of FRA:NPAU is €0.14 and 52 week low is €0.05.
When is next earnings date of BetterLife Pharma Inc(FRA:NPAU)?
The next earnings date of BetterLife Pharma Inc(FRA:NPAU) is .
Does BetterLife Pharma Inc(FRA:NPAU) pay dividends? If so, how much?
BetterLife Pharma Inc(FRA:NPAU) does not pay dividend.

Press Release

Subject Date
No Press Release